Relevant bibliographies by topics / SF-36 / Journal articles

Journal articles on the topic 'SF-36'

To see the other types of publications on this topic, follow the link: SF-36.
Author: Grafiati
Published: 4 June 2021
Last updated: 9 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'SF-36.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

&NA;. "SF-36." Journal of Orthopaedic Trauma 20, Supplement (September 2006): S70. http://dx.doi.org/10.1097/00005131-200609001-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Güthlin, Corina, and Harald Walach. "MOS-SF 36." European Journal of Psychological Assessment 23, no. 1 (January 2007): 15–23. http://dx.doi.org/10.1027/1015-5759.23.1.15.

Full text
Abstract:
The objective was to study the construct validity of the MOS SF-36 (Medical Outcome Study, short form questionnaire, version of 36 items) using structural equation modeling (SEM). Despite the widespread use of the questionnaire, several problems with the measurement model have been shown in the past, and it is highly disputable whether the computation of two component (summary) scales according to the published algorithm is a valid condensation. The SEM was conducted with the data of N = 2,874; the SF-36 was part of a questionnaire given prior to acupuncture treatment. The results indicated poor construct validity of the proposed structure of the first and second order factor solutions. First and foremost, contrary to the algorithm stated in the manual, the two component scales are not uncorrelated. Second, the overall fit of the original measurement model does not reflect the data structure very well. The current measurement model is discussed and starting points for revisions are provided.
APA, Harvard, Vancouver, ISO, and other styles
3

Hunt, S. M., and S. P. McKenna. "Validating the SF-36." BMJ 305, no. 6854 (September 12, 1992): 645–46. http://dx.doi.org/10.1136/bmj.305.6854.645-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gompertz, P., R. Harwood, S. Ebrahim, and E. Dickinson. "Validating the SF-36." BMJ 305, no. 6854 (September 12, 1992): 645–46. http://dx.doi.org/10.1136/bmj.305.6854.645-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Simon, Gregory E., Dennis A. Revicki, Louis Grothaus, and Michael Vonkorff. "SF-36 Summary Scores." Medical Care 36, no. 4 (April 1998): 567–72. http://dx.doi.org/10.1097/00005650-199804000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chang, Doris F., Chi-Ah Chun, David T. Takeuchi, and Haikang Shen. "SF-36 Health Survey." Medical Care 38, no. 5 (May 2000): 542–48. http://dx.doi.org/10.1097/00005650-200005000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

&NA;. "EuroQol compared with SF-36." Inpharma Weekly &NA;, no. 901 (August 1993): 8. http://dx.doi.org/10.2165/00128413-199309010-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

O'Dea, D., J. Kokaua, and M. Wheadon. "SF-36 health status questionnaire." Journal of Epidemiology & Community Health 49, no. 6 (December 1, 1995): 647. http://dx.doi.org/10.1136/jech.49.6.647.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ware, John E. "SF-36 Health Survey Update." Spine 25, no. 24 (December 2000): 3130–39. http://dx.doi.org/10.1097/00007632-200012150-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Davidson, M. B. "SF-36 and Diabetes Outcome Measures." Diabetes Care 28, no. 6 (May 26, 2005): 1536–37. http://dx.doi.org/10.2337/diacare.28.6.1536-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

&NA;. "Time to retire the SF 36?" Inpharma Weekly &NA;, no. 896 (July 1993): 10. http://dx.doi.org/10.2165/00128413-199308960-00021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Lüthi, Hansjörg. "Assessment: SF-36 – Lebensqualität transparent machen." ergopraxis 02, no. 09 (September 2009): 30–31. http://dx.doi.org/10.1055/s-0030-1253203.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Salazar, Fernando Raul, and Eduardo Bernabé. "The Spanish SF-36 in Peru." Asia Pacific Journal of Public Health 27, no. 2 (January 13, 2012): NP2372—NP2380. http://dx.doi.org/10.1177/1010539511432879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Brazier, J., R. Harper, N. Jones, K. Thomas, L. Westlake, and T. Usherwood. "Validating the SF-36: Authors' reply." BMJ 305, no. 6854 (September 12, 1992): 646. http://dx.doi.org/10.1136/bmj.305.6854.646.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Laaksonen, Mikko, Ossi Rahkonen, Pekka Martikainen, Sakari Karvonen, and Eero Lahelma. "Smoking and SF-36 health functioning." Preventive Medicine 42, no. 3 (March 2006): 206–9. http://dx.doi.org/10.1016/j.ypmed.2005.12.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Bjorner, Jakob B., Kate Thunedborg, Tage S. Kristensen, Jens Modvig, and Per Bech. "The Danish SF-36 Health Survey." Journal of Clinical Epidemiology 51, no. 11 (November 1998): 991–99. http://dx.doi.org/10.1016/s0895-4356(98)00091-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Leplège, Alain, Emmanuel Ecosse, Angela Verdier, and Thomas V. Perneger. "The French SF-36 Health Survey." Journal of Clinical Epidemiology 51, no. 11 (November 1998): 1013–23. http://dx.doi.org/10.1016/s0895-4356(98)00093-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Apolone, Giovanni, and Paola Mosconi. "The Italian SF-36 Health Survey." Journal of Clinical Epidemiology 51, no. 11 (November 1998): 1025–36. http://dx.doi.org/10.1016/s0895-4356(98)00094-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Bellach, B. M., U. Ellert, and M. Radoschewski. "Der SF-36 im Bundes-Gesundheitssurvey." Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 43, no. 3 (March 15, 2000): 210–16. http://dx.doi.org/10.1007/s001030050036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Crome, P., RA Lyons, J. Gene, J. C. Contel, E. Gonzalo, A. Bono, P. Sovery, et al. "The SF-36 in Older Europeans." Age and Ageing 27, suppl 1 (January 1, 1998): P44. http://dx.doi.org/10.1093/ageing/27.suppl_1.p44-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Huber, J., I. Satkauskas, R. Theiler, M. Zumstein, and G. Ruflin. "Klinische Resultate 2 Jahre nach Hüfttotalendoprothese (WOMAC/SF-36) und Vergleich mit der Normbevölkerung (SF-36)." Zeitschrift für Orthopädie und ihre Grenzgebiete 144, no. 03 (July 4, 2006): 296–300. http://dx.doi.org/10.1055/s-2006-933443.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

van Tetering, Elisabeth A. A., and Richard E. Buckley. "Functional Outcome (SF-36) of Patients with Displaced Calcaneal Fractures Compared to SF-36 Normative Data." Foot & Ankle International 25, no. 10 (October 2004): 733–38. http://dx.doi.org/10.1177/107110070402501007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kiely, M., K. Weidner, and J. Weigelt. "Correlation of SF-36 and SF-12 in a trauma population." Journal of Surgical Research 130, no. 2 (February 2006): 227–28. http://dx.doi.org/10.1016/j.jss.2005.11.186.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Kiely, James M., Karen J. Brasel, Clare E. Guse, and John A. Weigelt. "Correlation of SF-12 and SF-36 in a Trauma Population." Journal of Surgical Research 132, no. 2 (May 2006): 214–18. http://dx.doi.org/10.1016/j.jss.2006.02.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Ware, John E., and Cathy Donald Sherbourne. "The MOS 36-ltem Short-Form Health Survey (SF-36)." Medical Care 30, no. 6 (June 1992): 473–83. http://dx.doi.org/10.1097/00005650-199206000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

MCHORNEY, COLLEEN A., WARE JOHNE, and RACZEK ANASTASIAE. "The MOS 36-Item Short-Form Health Survey (SF-36)." Medical Care 31, no. 3 (March 1993): 247–63. http://dx.doi.org/10.1097/00005650-199303000-00006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Nortvedt, Monica W., Trond Riise, Kjell-Morten Myhr, and Harald I. Nyland. "Performance of the SF-36, SF-12, and RAND-36 Summary Scales in a Multiple Sclerosis Population." Medical Care 38, no. 10 (October 2000): 1022–28. http://dx.doi.org/10.1097/00005650-200010000-00006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Pless, I. "The SF-36: not suitable for children." Injury Prevention 2, no. 2 (June 1, 1996): 82–83. http://dx.doi.org/10.1136/ip.2.2.82-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Khanna, D., G. S. Park, and J. Seibold. "SF-36 Scales in the Relaxin study." Rheumatology 46, no. 4 (October 13, 2006): 724. http://dx.doi.org/10.1093/rheumatology/kem009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Jerosch, J., and M. Floren. "Lebensqualitätsgewinn (SF-36) nach Implantation einer Knieendoprothese." Der Unfallchirurg 103, no. 5 (May 2000): 371–74. http://dx.doi.org/10.1007/s001130050552.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

GLADMAN, JOHN R. F. "Assessing health status with the SF-36." Age and Ageing 27, no. 1 (1998): 3. http://dx.doi.org/10.1093/ageing/27.1.3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Hagell, P., A. L. Törnqvist, and J. Hobart. "Testing the SF-36 in Parkinson's disease." Journal of Neurology 255, no. 2 (January 22, 2008): 246–54. http://dx.doi.org/10.1007/s00415-008-0708-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Wang, P., N. Luo, E. S. Tai, J. Lee, H. L. Wee, and J. Thumboo. "PRM35 Relative Efficiency of the SF-8, SF-12, and SF-36 in the General Population." Value in Health 15, no. 7 (November 2012): A651. http://dx.doi.org/10.1016/j.jval.2012.08.286.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Kitajima, Izuru, Kazureru Doi, Yasunori Hattori, Semih Takka, and Emmanuel Estrella. "EVALUATION OF QUALITY OF LIFE IN BRACHIAL PLEXUS INJURY PATIENTS AFTER RECONSTRUCTIVE SURGERY." Hand Surgery 11, no. 03 (January 2006): 103–7. http://dx.doi.org/10.1142/s0218810406003279.

Full text
Abstract:
To evaluate the subjective satisfaction of brachial plexus injury (BPI) patients after surgery based on the medical outcomes study 36-item short form health survey (SF-36) and to correlate their SF-36 scores with upper extremity functions. Four items were assessed statistically for 30 patients: SF-36 scores after BPI surgery were compared with Japanese standard scores; the correlation between SF-36 scores and objective joint functions; difference in SF-36 scores between each type of BPI; and influence of each joint function on the SF-36 scores. The SF-36 subscale: PF — physical functioning, RP — role-physical, BP — bodily pain, and the summary score PCS — physical component summary, were significantly inferior to the Japanese standard scores. SF-36 is more sensitive to shoulder joint function than to elbow and finger joint functions. Little correlation was found between SF-36 scores and objective evaluations of joint functions. Greater effort is needed to improve the quality of life (QOL) of BPI patients. This study showed that SF-36 is not sensitive enough to evaluate regional conditions. A region- or site-specific questionnaire is required to evaluate upper extremity surgery.
APA, Harvard, Vancouver, ISO, and other styles
35

Julious, S. A., S. George, and M. J. Campbell. "Sample sizes for studies using the short form 36 (SF-36)." Journal of Epidemiology & Community Health 49, no. 6 (December 1, 1995): 642–44. http://dx.doi.org/10.1136/jech.49.6.642.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

van der Meulen, Merel, Amir H. Zamanipoor Najafabadi, Daniel J. Lobatto, Cornelie D. Andela, Thea P. M. Vliet Vlieland, Alberto M. Pereira, Wouter R. van Furth, and Nienke R. Biermasz. "SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements." Endocrine 70, no. 1 (June 19, 2020): 123–33. http://dx.doi.org/10.1007/s12020-020-02384-4.

Full text
Abstract:
Abstract Purpose Pituitary diseases severely affect patients’ health-related quality of life (HRQoL). The most frequently used generic HRQoL questionnaire is the Short Form-36 (SF-36). The shorter 12-item version (SF-12) can improve efficiency of patient monitoring. This study aimed to determine whether SF-12 can replace SF-36 in pituitary care. Methods In a longitudinal cohort study (August 2016 to December 2018) among 103 endoscopically operated adult pituitary tumor patients, physical and mental component scores (PCS and MCS) of SF-36 and SF-12 were measured preoperatively, and 6 weeks and 6 months postoperatively. Chronic care was assessed with a cross-sectional study (N = 431). Mean differences and agreement between SF-36 and SF-12 change in scores (preoperative vs. 6 months) were assessed with intraclass correlation coefficients (ICC) and limits of agreement, depicting 95% of individual patients. Results In the longitudinal study, mean differences between change in SF-36 and SF-12 scores were 1.4 (PCS) and 0.4 (MCS) with fair agreement for PCS (ICC = 0.546) and substantial agreement for MCS (ICC = 0.931). For 95% of individual patients, the difference between change in SF-36 and SF-12 scores varied between −14.0 and 16.9 for PCS and between −7.8 and 8.7 for MCS. Cross-sectional results showed fair agreement for PCS (ICC = 0.597) and substantial agreement for MCS (ICC = 0.943). Conclusions On a group level, SF-12 can reliably reproduce MCS in pituitary patients, although PCS is less well correlated. However, individual differences between SF-36 and SF-12 can be large. For pituitary diseases, alternative strategies are needed for concise, but comprehensive patient-reported outcome measurement.
APA, Harvard, Vancouver, ISO, and other styles
37

Pickard, A. Simon, Jeffrey A. Johnson, Andrew Penn, Francis Lau, and Tom Noseworthy. "Replicability of SF-36 Summary Scores by the SF-12 in Stroke Patients." Stroke 30, no. 6 (June 1999): 1213–17. http://dx.doi.org/10.1161/01.str.30.6.1213.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Gonchar, M. O., O. V. Omelchenko, M. I. Strelkova, and M. M. Yermolaev. "DETECTION OF PSYCHOLOGICAL CHARACTERISTICS IN CHILDREN WITH CHRONIC GASTROINTESTINAL DISEASES USING MOS-SF-36QUESTIONNAIRE." Inter Collegas 4, no. 1 (April 17, 2017): 20–22. http://dx.doi.org/10.35339/ic.4.1.20-22.

Full text
Abstract:
DETECTION OF PSYCHOLOGICAL CHARACTERISTICS IN CHILDREN WITH CHRONIC GASTROINTESTINAL DISEASES USING MOS-SF-36QUESTIONNAIREGonchar M.O., Omelchenko O.V., Strelkova M.I., Yermolayev M.M.The article describes the main approaches in the study of psychological characteristics in children with chronic gastroenterological diseases according to MOS SF-36 questionnaire.Key words: children, MOS-SF-36questionnaire, chronic gastrointestinal diseases. ВИЗНАЧЕННЯ ПСИХОЛОГІЧНИХ ХАРАКТЕРИСТИК ДІТЕЙ З ХРОНІЧНИМИ ГАСТРОІНТЕСТИНАЛЬНИМИ ЗАХВОРЮВАННЯМИ З ВИКОРИСТАННЯМ ОПИТУВАЛЬНИКА MOS-SF-36Гончарь М.О., Омельченко О.В., Стрелкова М.І, Єрмолаєв М.М.В статті викладено основні дослідження фізичних та психологічних особливостей у дітей з хронічною гастроентерологічною патологією за даними опитувальника MOS SF-36.Ключові слова: діти, опитувальник MOS-SF-36, хронічна гастроентерологічна патологія. ОПРЕДЕЛЕНИЕ ПСИХОЛОГИЧЕСКИХ ХАРАКТЕРИСТИК ДЕТЕЙ З ХРОНИЧЕСКИМИ ГАСТРОИНТЕСТИНАЛЬНЫМИ ЗАБОЛЕВАНИЯМИ С ИСПОЛЬЗОВАНИЕМ ОПРОСНИКА MOS-SF-36Гончарь М.А., Омельченко Е.В., Стрелкова М.И., Ермолаев М.Н. В статье изложены основные подходы исследования психологических особенностей у детей с хронической гастроэнтерологической патологией по данным опросника MOS SF-36.Ключевые слова: дети, опросник MOS-SF-36, хроническая гастроэнтерологическая патология.
APA, Harvard, Vancouver, ISO, and other styles
39

Burholt, V., and P. Nash. "Short Form 36 (SF-36) Health Survey Questionnaire: normative data for Wales." Journal of Public Health 33, no. 4 (February 9, 2011): 587–603. http://dx.doi.org/10.1093/pubmed/fdr006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Stewart, Mark. "The Medical Outcomes Study 36-item short-form health survey (SF-36)." Australian Journal of Physiotherapy 53, no. 3 (2007): 208. http://dx.doi.org/10.1016/s0004-9514(07)70033-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Aseeva, E., S. Solovyev, S. Glukhova, and A. Lila. "AB0481 HEALTH-RELATED QUALITY OF LIFE ASSESSED BY LupusQoL AND SF-36 IN 400 RUSSIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1368.1–1368. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1569.

Full text
Abstract:
BackgroundThe LupusQoL is a disease-specific health-related quality of life (HRQoL) measure for patients with lupus.ObjectivesWe conducted this study to compare the efficiency of LupusQoL with the 36-item Short-Form Health Survey (SF-36), a generic quality of life (QoL) scale, in Russian patients with lupus. Both questionnaires were conducted for one visit to the clinic.MethodsDisease activity was evaluated by the SLEDAI-2K, and chronic damage by the Systemic Lupus International Collaborating Clinics Damage Index score (SDI). Associations between the LupusQoL and SF-36 domains were examined, while also examining age, disease duration, and disease activity for each questionnaire. Descriptive statistics, Spearman’s correlation coefficients, and Students t test were performed to analyze the data.ResultsA total of 400 patients with lupus (F/M 363:37, mean age 34,2±11.5 years, mean disease duration 106,3±91,9.0 months) were included, and 63 % of these were active and 56 % of these had SDI≥1. The mean SLEDAI 2K score was 9,6±8,0.QOL as assessed by SF-36 and LupusQoL was low in this group of patients with SLE. The mean scores for each of the domains of the LupusQoL and SF-36 are shown in Table 1. The mean scores are < 60 in 8 domains of the SF-36 but not in social functioning (62,03±27,19) and physical function (62,35±28,53).Table 1.Descriptive statistics and correlation coefficient for SF-36 and LupusQoLLupusQoLdomainsMean (SD)SF-36domainsMean (SD)rPComparablePhysical health66,20±23,18PF62,35±28,530,770,96Emotional health64,65±24,75MH50,51±8,400,380,94Pain70,03±24,68BP47,0±8,86-0,330,02Fatigue62,7±24,73VT53,04±22,59-0,700,83NoncomparablePlanning63,90±28,46SF62,03±27,19Intimaterelationships72,92±30,93GH49,14±20,51Burden to others50,68±27,79RE49,84±43,86Body image65,18±27,60RP40,46±41,35PCS45,15±7,65MCS48,46±5,41The MCS and PCS scores were both < 50. Despite the fact that the mean score in LupusQoL was always higher than in SF-36 for each of the comparable domains, 3 standardized p values were not statistically significant (mean score in 400 patient visits: physical health/physical function, 66,20±23,18/62,35±28,53, p = 0.96; emotional health/mental health, 64,65±24,75/50,51±8,40, p = 0.94; and fatigue/vitality 62.70 ± 24.73/53.04 ± 22.59, p = 0.83), 1 standardized p value was statistically significant - pain/bodily pain 70.03 ± 24.68/47.00 ± 8.86, p = 0.02. The correlation of the comparable domains of LupusQoL and SF-36 was studied. There was a strong correlation between comparable domains in LupusQoL and SF-36 in 400 patient visits (physical health and physical functioning, r = 0.77; emotional health and role emotional, r = 0.38; pain and bodily pain, r = -0,33; and fatigue and vitality, r =- 0.70; all p values < 0.0001).For the 4 non-comparable domains of the LupusQoL, there was a correlation between 3 domains of LupusQoL and 1 of the component scores of SF-36: body image and SF-36 MCS, r = 0.20; planning and SF-36 MCS, r = 0.13, r = 0.73; and burden to others and SF-36 MCS, r = 0.19; body image and SF-36 PCS,r=0,38; planning and SF-36 PCS,r=0,66; and burden to others and SF-36 PCS,r=0,38.ConclusionThe LupusQoL-Russian is sensitive to change in SLE patients with active SLE. LupusQoL and SF-36 were equivalent in assessing the HRQOL in the Russian SLE patients. Both LupusQoL and SF-36 are easily completed by patients and correlate very well with each other.Disclosure of InterestsNone declared
APA, Harvard, Vancouver, ISO, and other styles
42

Jenkinson, Crispin, and Richard Layte. "Development and Testing of the UK SF-12." Journal of Health Services Research & Policy 2, no. 1 (January 1997): 14–18. http://dx.doi.org/10.1177/135581969700200105.

Full text
Abstract:
Objectives: The 36 item short form health survey (SF-36) has proved to be of use in a variety of settings where a short generic health measure of patient-assessed outcome is required. This measure can provide an eight dimension profile of health status, and two summary scores assessing physical function and mental well-being. The developers of the SF-36 in America have developed algorithms to yield the two summary component scores in a questionnaire containing only one-third of the original 36 items, the SF-12. This paper documents the construction of the UK SF-12 summary measures from a large-scale dataset from the UK in which the SF-36, together with other questions on health and lifestyles, was sent to randomly selected members of the population. Using these data we attempt here to replicate the findings of the SF-36 developers in the UK setting, and then to assess the use of SF-12 summary scores in a variety of clinical conditions. Methods: Factor analytical methods were used to derive the weights used to construct the physical and mental component scales from the SF-36. Regression methods were used to weight the 12 items recommended by the developers to construct the SF-12 physical and mental component scores. This analysis was undertaken on a large community sample ( n = 9332), and then the results of the SF-36 and SF-12 were compared across diverse patient groups (Parkinson's disease, congestive heart failure, sleep apnoea, benign prostatic hypertrophy). Results: Factor analysis of the SF-36 produced a two factor solution. The factor loadings were used to weight the physical component summary score (PCS-36) and mental component summary score (MCS-36). Results gained from the use of these measures were compared with results gained from the PCS-12 and MCS-12, and were found to be highly correlated (PCS: ρ = 0.94, p < 0.001; MCS: ρ = 0.96, p < 0.001), and produce remarkably similar results, both in the community sample and across a variety of patient groups. Conclusions: The SF-12 is able to produce the two summary scales originally developed from the SF-36 with considerable accuracy and yet with far less respondent burden. Consequently, the SF-12 may be an instrument of choice where a short generic measure providing summary information on physical and mental health status is required. Crispin Jenkinson DPhil, Deputy Director
APA, Harvard, Vancouver, ISO, and other styles
43

KORKEM, Duygu, Hamide Elif ÖZTÜRK, and Nurgül DÜRÜSTKAN ELBAŞI. "INVESTIGATION OF CHANGES IN KINESOPHOBIA, SLEEP QUALITY AND LIFE QUALITY AFTER LUMBAR DISC HERNIA SURGERY." Sağlık Akademisi Kastamonu 7, no. 3 (December 1, 2022): 3–4. http://dx.doi.org/10.25279/sak.1040104.

Full text
Abstract:
Amaç: Lomber disk hernisi (LDH) tanısı koyulan ve mikrodiskektomi cerrahisi geçiren bireylerde kinezyofobi, günlük yaşam aktiviteleri ve uyku kalitesinin değişimini araştırmaktır. Materyal&amp;Method: LDH cerrahisi endikasyonu olup, cerrahi olan 30 hasta çalışmaya dahil edildi. Hastalar ameliyattan önce, ameliyat sonrası birinci, üçüncü ve altıncı aylarda değerlendirildi. Hastaların değerlendirilmesinde kısa form Mcgill ağrı anketi, görsel ağrı skalası (VAS), Oswestry disabilite indeksi (ODİ), Tampa kinezyofobi ölçeği (TKÖ), SF-36 yaşam kalitesi ölçeği ve Pittsburg Uyku Kalitesi İndeksi (PUKİ) kullanıldı. Ayrıca hastaların lomber fleksiyon-ekstansiyon ve lateral fleksiyon normal eklem hareket açıları (NEH) kaydedildi. Hastalara ameliyat sonrası önerilerde bulunuldu. Ev egzersiz programı verildi. Bulgular: Değerlendirmeler sonucunda SF-36’nın bütün alt parametrelerinde, TKÖ, PUKİ ve NEH’lerinin zaman içindeki değişimi anlamlı bulundu (p&lt;0.05). Ameliyat öncesi lomber bölge fleksiyon hareketi ile TKÖ, ODİ Toplam Skoru arasında; VAS skoru ile PUKİ toplam skoru ve SF-36 Emosyonel iyilik hali alt bileşeni arasında; VAS değeri ile PUKİ toplam skoru ve SF-36 Emosyonel iyilik hali alt bileşeni arasında; Mc-Gill duyusal (sensory) alt parametresi ile SF-36 Vücut ağrısı alt bileşeni arasında; Mc-Gill algısal alt parametresi ile TKÖ, Mc-Gill toplam Skoru ile SF-36 Fiziksel problemler nedeniyle olan kısıtlanma alt bileşeni arasında anlamlı ilişki bulundu (p&lt;0,05). 6. ayda PUKİ skoru ile SF-36 Fiziksel problemler nedeniyle olan kısıtlanma ve SF-36 Genel Sağlık Algısı alt bileşeni arasında; SF-36 Emosyonel iyilik hali ve SF-36 Genel Sağlık Algısı alt bileşeni arasında istatistiksel olarak anlamlı ilişki bulundu (p&lt;0,05). Sonuç: LDH cerrahisi ve sonrasında erken dönemden itibaren verilen, aşamalı olarak arttırılan ev egzersiz programı bireylerin subjektif ve objektif bulgularında önemli düzeyde iyileşmeler sağladı.
APA, Harvard, Vancouver, ISO, and other styles
44

Faiq I. Gorial and Mais Ajeel Jabbar. "Quality of life assessment in behçet’s disease: an observational case control single center study." International Journal of Research in Pharmaceutical Sciences 10, no. 4 (October 16, 2019): 2607–11. http://dx.doi.org/10.26452/ijrps.v10i4.1518.

Full text
Abstract:
Behçet’s disease (BD) is a multisystemic inflammatory disorder characterized by recurrent exacerbations. Limited studies have shown it has a negative impact on patients quality of life(QoL). This study aimed to evaluate Quality of Life in Patients with Behçet’s disease compared with healthy controls. A case-control study involved 71 patients with BD compared with 71 healthy controls matched in age and sex. Health-related quality-of-life was evaluated using the Short Form-36 (SF-36). All the components of Short Form-36 (SF-36), it's summary scores, and Total Short Form-36 (Total SF-36) score was significantly lower (p-value <0.001 ) in patients compared to controls. Each organ involvement studied may affect independently specific SF-36 subscores. Central nervous system involvement in BD had a strong impact since it affects most of the SF-36 subscores. In conclusion: Health-related Quality of life was significantly impaired in Iraqi patients with Behçet’s disease compared to healthy controls. Each organ involvement studied may affect independently specific SF-36 subscores.
APA, Harvard, Vancouver, ISO, and other styles
45

Taft, Charles, Jan Karlsson, and Marianne Sullivan. "Performance of the Swedish SF-36 version 2.0." Quality of Life Research 13, no. 1 (February 2004): 251–56. http://dx.doi.org/10.1023/b:qure.0000015290.76254.a5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Horner-Johnson, Willi, Gloria Krahn, Rie Suzuki, Jana Peterson, Gale Roid, and Trevor Hall. "Evidence of Functional Bias in the SF-36." Disability and Health Journal 3, no. 2 (April 2010): e4. http://dx.doi.org/10.1016/j.dhjo.2009.08.080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Dahlof, C. "The SF-36 and the assessment of HRQoL." Cephalalgia 18, no. 9 (November 1998): 592. http://dx.doi.org/10.1046/j.1468-2982.1998.1809591-4.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Ware, John E., Susan D. Keller, Hind T. Hatoum, and Sheldon Xiaodong Kong. "The SF-36 Arthritis-Specific Health Index (ASHI)." Medical Care 37, SUPPLEMENT (May 1999): MS40—MS50. http://dx.doi.org/10.1097/00005650-199905001-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Keller, Susan D., John E. Ware, Hind T. Hatoum, and Sheldon Xiaodong Kong. "The SF-36 Arthritis-Specific Health Index (ASHI)." Medical Care 37, SUPPLEMENT (May 1999): MS51—MS60. http://dx.doi.org/10.1097/00005650-199905001-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Reed, Pamala J., and D. DeWayne Moore. "SF-36 as A Predictor of Health States." Value in Health 3, no. 3 (May 2000): 202–7. http://dx.doi.org/10.1046/j.1524-4733.2000.33005.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'SF-36' for other source types:
Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography